A phase I/II study of gemcitabine and fractionated cisplatin in an outpatient setting using a 21-day schedule in patients with advanced and metastatic bladder cancer.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples